Literature DB >> 21799072

Lung cancer in patients with chronic obstructive pulmonary disease-- incidence and predicting factors.

Juan P de Torres1, Jose M Marín, Ciro Casanova, Claudia Cote, Santiago Carrizo, Elizabeth Cordoba-Lanus, Rebeca Baz-Dávila, Javier J Zulueta, Armando Aguirre-Jaime, Marina Saetta, Manuel G Cosio, Bartolome R Celli.   

Abstract

RATIONALE: Little is known about the clinical factors associated with the development of lung cancer in patients with chronic obstructive pulmonary disease (COPD), although airway obstruction and emphysema have been identified as possible risk factors.
OBJECTIVES: To explore incidence, histologic type, and factors associated with development of lung cancer diagnosis in a cohort of outpatients with COPD attending a pulmonary clinic.
METHODS: A cohort of 2,507 patients without initial clinical or radiologic evidence of lung cancer was followed a median of 60 months(30–90). At baseline, anthropometrics, smoking history, lung function,and body composition were recorded. Time to diagnosis and histologic type of lung cancer was then registered. Cox analysis was used to explore factors associated with lung cancer diagnosis.
MEASUREMENTS AND MAIN RESULTS: A total of 215 of the 2,507 patients with COPD developed lung cancer (incidence density of 16.7 cases per 1,000 person-years). The most frequent type was squamous cell carcinoma (44%). Lung cancer incidence was lower in patients with worse severity of airflow obstruction. Global Initiative for Chronic Obstructive Lung Disease Stages I and II, older age, lower body mass index,and lung diffusion capacity of carbon monoxide less than 80%were associated with lung cancer diagnosis.
CONCLUSIONS: Incidence density of lung cancer is high in outpatients with COPD and occurs more frequently in older patients with milder airflow obstruction (Global Initiative for Chronic Obstructive Lung Disease Stages I and II) and lower body mass index. A lung diffusion capacity of carbon monoxide less than 80% is associated with cancer diagnosis. Squamous cell carcinoma is the most frequent histologic type. Knowledge of these factors may help direct efforts for early detection of lung cancer and disease management.

Entities:  

Mesh:

Year:  2011        PMID: 21799072     DOI: 10.1164/rccm.201103-0430OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  88 in total

Review 1.  Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Authors:  Mathew Suji Eapen; Philip M Hansbro; Anna-Karin Larsson-Callerfelt; Mohit K Jolly; Stephen Myers; Pawan Sharma; Bernadette Jones; Md Atiqur Rahman; James Markos; Collin Chia; Josie Larby; Greg Haug; Ashutosh Hardikar; Heinrich C Weber; George Mabeza; Vinicius Cavalheri; Yet H Khor; Christine F McDonald; Sukhwinder Singh Sohal
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

Review 2.  Lung injury and lung cancer caused by cigarette smoke-induced oxidative stress: Molecular mechanisms and therapeutic opportunities involving the ceramide-generating machinery and epidermal growth factor receptor.

Authors:  Tzipora Goldkorn; Simone Filosto; Samuel Chung
Journal:  Antioxid Redox Signal       Date:  2014-07-01       Impact factor: 8.401

3.  [Clinical characteristics and risk factors affecting outcomes of elderly patients with non-small cell lung cancer complicated by chronic obstructive pulmonary disease].

Authors:  Peng Wang; Dong Zhang; Xue-Guang Guo; Bao-Jun Sun; Xiang-Qun Fang; Ge-Ping Qu; Chang-Ting Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-07-20

4.  Coexistence of Emphysema With Non-small-cell Lung Cancer Predicts the Therapeutic Efficacy of Immune Checkpoint Inhibitors.

Authors:  Yusuke Takayama; Takashi Nakamura; Yuki Fukushiro; Shohei Mishima; Ken Masuda; Hiroyasu Shoda
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

5.  Reduced Expiratory Flow Rate among Heavy Smokers Increases Lung Cancer Risk. Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort.

Authors:  Raewyn J Hopkins; Fenghai Duan; Caroline Chiles; Erin M Greco; Greg D Gamble; Denise Aberle; Robert P Young
Journal:  Ann Am Thorac Soc       Date:  2017-03

6.  Long-acting muscarinic antagonist and long-acting β2-agonist therapy to optimize chronic obstructive pulmonary disease prior to lung cancer surgery.

Authors:  Takashi Makino; Hajime Otsuka; Yoshinobu Hata; Satoshi Koezuka; Yoko Azuma; Kazutoshi Isobe; Keishi Sugino; Satoru Ebihara; Sakae Homma; Akira Iyoda
Journal:  Mol Clin Oncol       Date:  2018-03-26

7.  Functional polymorphisms in NFκB1/IκBα predict risks of chronic obstructive pulmonary disease and lung cancer in Chinese.

Authors:  Dongsheng Huang; Lei Yang; Yehua Liu; Yumin Zhou; Yuan Guo; Mingan Pan; Yunnan Wang; Yigang Tan; Haibo Zhong; Min Hu; Wenju Lu; Weidong Ji; Jian Wang; Pixin Ran; Nanshan Zhong; Yifeng Zhou; Jiachun Lu
Journal:  Hum Genet       Date:  2013-01-16       Impact factor: 4.132

8.  Thoracoscopic minimally invasive surgery for non-small cell lung cancer in patients with chronic obstructive pulmonary disease.

Authors:  Fei Cui; Jun Liu; Wenlong Shao; Jianxing He
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

Review 9.  Lung cancer screening in patients with chronic obstructive pulmonary disease.

Authors:  Jessica Gonzalez; Marta Marín; Pablo Sánchez-Salcedo; Javier J Zulueta
Journal:  Ann Transl Med       Date:  2016-04

10.  Overwhelming support among urban Irish COPD patients for lung cancer screening by low-dose CT scan.

Authors:  M Pallin; S Walsh; M F O'Driscoll; C Murray; A Cahalane; L Brown; M Carter; P Mitchell; T J McDonnell; M W Butler
Journal:  Lung       Date:  2012-10-12       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.